Data MATRIX Introduces an AI-Operated Patient Survival Assessment Tool

Data MATRIXData MATRIX, a sole Real-World Evidence solutions provider in Russia, has presented a predictive analytics tool for estimating patient survival based on Real-World Data.

An important feature of the presented tool for predictive analysis of Real-World Data is its countrywide potential, and the ability to collect and analyze data on different patient cohorts. That in turn allows the estimation of the survival of a patient based on their individual parameters and performed or planned treatment, before being compared with the best treatment option for similar baseline data. Machine algorithms collect information about patients from medical records received from prevention and treatment facilities, pharmaceutical companies, and researchers in 29 regions of the Russian Federation.

The tool demonstration took place at Skolkovo Innovation Center with the participation of the Russian Ministry of Health, and the Russian Ministry of Economic Development. The event was also attended by representatives of major international and Russian pharmaceutical manufacturers such as Novartis, Janssen, and R-Pharm.

The company's medical director, Polina Shpigotskaya, held a live demonstration of the tool's capabilities to the participants, using breast cancer patients as an example. However, the product is also suitable for other therapeutic areas. In real time, the system processed the information about cancer patients with specified parameters, such as sex, age, degree of malignancy, and menopause status, and displayed in graphs and excel tables the prognosis of survival with the best treatment option for the cohort. The company plans to expand the functionality of the platform, increase the database through partnerships with medical institutions, and scale up the system throughout the Russian Federation.

The event was preceded by Russian President’s Vladimir Putin signing Federal Law which established a regulatory sandbox for 7 digitally innovative projects. Data MATRIX was among the 7 projects that can operate within this legal regime. Under the law, Data MATRIX can process personal data derived from electronic healthcare records (EHRs) in an anonymized form. The company will be able to conduct retrospective clinical studies without signing informed consent and obtain anonymized data from healthcare facilities and data integrators.

As a result, pharmaceutical and biotech companies will have a legally compliant provider of Real-world data (RWD) derived from millions of EHRs. This will contribute to the overall knowledge base on drugs efficacy and safety, including those of vaccines.

For further information, please visit:
https://dm-matrix.com

About Data MATRIX

Data MATRIX RWE offers a wide range of Real World Evidence (RWE) solutions with access to millions of electronic health records. This start-up also delivers clinical data management and biostatistics services and develops software for clinical research. To date, the DM RWE portfolio includes over 200 projects for pharmaceutical and biotechnology companies and CROs. DM RWE products include applications such as EDC, IWRS and ePRO. The company is a member of CDISC, ACDM, SCDM and other professional communities.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...